CAS 13311-84-7 Flutamide API Active Pharmaceutical Ingredient Androgen Receptor Antagonist Non Steroidal

Basic Information
Place of Origin: China
Minimum Order Quantity: Negotiation
Price: Negotiation
Packaging Details: Drum/Bag
Delivery Time: Negotiation
Payment Terms: L/C, D/A, D/P, T/T
Supply Ability: Negotiation
Cas No: 13311-84-7 Ec No: 236-341-9
Molecular Formula: C11H11F3N2O3 Molecular Weight: 276.21
Melting Point: 112 °C Boiling Point: 400.3±45.0 °C
Density: 1.3649
High Light:

CAS NO 13311-84-7


13311-84-7 Flutamide api


flutamide api manufacturers

Flutamide;CAS 13311-84-7;API



Name Flutamide
Molecular Formula C11H11F3N2O3
Molecular Weight 276.21
CAS Registry Number 13311-84-7
EINECS Number 236-341-9
Melting point 112 °C
density 1.3649
Boiling point 400.3±45.0 °C


Product Description:


Flutamide is a kind of synthetic, non-steroidal antiandrogen which is mainly used for the treatment of prostate cancer. It is a kind of toluidine derivative and a nonsteroidal antiandrogen with a similar structure of bicalutamide and nilutamide. The mechanism of its anti-cancer property is through acting as a selective antagonist of the androgen receptor (AR), preventing androgens such as testosterone and its active metabolite dihydrotestosterone from binding to ARs in the prostate gland. This process inhibits androgen-dependent DNA and protein synthesis in the tumor cell. Therefore, it can prevent androgens from stimulating the growth of prostate cancer cells. Moreover, it can also be used for the treatment of hyperandrogenism in women. It is quite effective in alleviating symptoms such as acne, seborrhea, hirsutism and androgenetic alopecia. Finally, it is also useful as a component in the transgender hormone therapy.



Product Use:


Flutamide is a nonsteroidal antiandrogen drug; antineoplastic (hormonal).

Besides prostate cancer, flutamide has also been tested and/or used off-label in other hyperandrogenism-related disorders like benign prostatic hyperplasia, acne vulgaris, and hirsutism syndrome. Due to its teratogenic potential, flutamide is restricted for premenopausal women and used only in combination with effective contraception.



CAS 13311-84-7 Flutamide API Active Pharmaceutical Ingredient Androgen Receptor Antagonist Non Steroidal 0


Product Catalogue:




Number Cas Name
1 62-46-4 Alpha Lipoic Acid
2 303-98-0 Coenzyme Q10
3 6020-87-7 Creatine Monohydrate
4 110-17-8 Fumaric Acid
5 3416-24-8 Glucosamine
6 87-89-8 Inositol
7 73-22-3 L-Tryptophan
8 56-87-1 L-Lysine
9 24634-61-5 Potassium Sorbate
10 56038-13-2 Sucralose
11 107-35-7 Taurine
12 128-13-2 Ursodeoxycholic Acid/ UDCA
13 59-43-8 Vitamin B1
14 83-88-5 Vitamin B2
15 8059-24-310 Vitamin B6
16 68-19-9 Vitamin B12
17 50-81-7 Vitamin C
18 1406-18-4 Vitamin E
19 11138-66-2 Xanthan Gum


About us



Zhejiang chemical import and export co., LTD. (zhejiang), formerly known as zhejiang branch of China national chemical import and export corporation, was established in December 1980. In 1988, he was transferred from Sinochem Corporation to be in charge of Zhejiang Provincial Department of Commerce and was renamed Zhejiang Chemical Import and Export Company. In 2003, the company changed its name to Zhejiang Chemical Import and Export Co., Ltd after the reform of state-owned enterprise shareholding system.

In 2008, it was incorporated into Zhejiang International Trade Group (one of the top 500 enterprises in China) and became the core member of the group's business circulation sector. The registered capital of the company is 72.5 million yuan, of which 38% are owned by the state and 62% are owned by employees.
There are 195 employees in the company, more than 79% of whom have bachelor's degree, 36% of whom are graduate students, and more than 90% of the salesmen have pharmaceutical and chemical background. The company is mainly engaged in the import and export trade of pharmaceutical raw materials and intermediates, dyes, pesticides, basic chemicals, fine chemicals, food and feed additives, pharmaceutical preparations and other products. The company has established close economic and trade relations with more than 100 countries and regions around the world. The company has wholly-owned subsidiaries Ruike International Trade Co., Ltd., Zhejiang Ruikai Chemical Co., Ltd., Zhejiang Fukai Import and Export Co., Ltd., joint-stock enterprise Zhejiang Aotokang Pharmaceutical Group Co., Ltd.
In recent years, especially since the establishment of the new team in 2019, the company has adhered to the development led by the party building, energized by reform, and improved efficiency by management. The company has shown a steady upward momentum of development. In 2020, the company achieved revenue of 3.337 billion yuan, total profit of 56.12 million yuan, total import and export of 450 million dollars.

In 2019, the company was rated as China Council for the Promotion of International Trade (CCPIT) Recommended Certification Enterprise, Top 100 International Pharmaceutical Enterprises -- a high-quality supplier and partner in the international market; In 2020, Zhejiang Provincial Department of Commerce and other units rated as the province's epidemic prevention and medical materials import outstanding contribution enterprise, Zhejiang Provincial Tax Bureau identified as the export tax rebate enterprises.

Contact Details
William Wang

Phone Number : +86-13588430486

WhatsApp : +8613588430486